NVO

Novo Nordisk ADR

Oct 17 • 04:00PM ET

54.37

-1.72 -3.07 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PPH AVDE PID JAVA WCMI PVAL APIE RVER DFIC DIVZ

Index	-	P/E	14.98	EPS (ttm)	3.63	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	-4.50%
Market Cap	183.02B	Forward P/E	13.45	EPS next Y	4.04	Insider Trans	-	Shs Float	3.37B	Perf Month	-12.09%
Enterprise Value	195.66B	PEG	1.33	EPS next Q	0.78	Inst Own	9.21%	Short Float	0.93%	Perf Quarter	-16.25%
Income	16.18B	P/S	4.03	EPS this Y	17.94%	Inst Trans	-1.46%	Short Ratio	1.75	Perf Half Y	-6.39%
Sales	45.45B	P/B	9.13	EPS next Y	8.37%	ROA	25.10%	Short Interest	31.46M	Perf YTD	-36.79%
Book/sh	5.95	P/C	61.44	EPS next 5Y	11.26%	ROE	75.95%	52W High	119.07 -54.34%	Perf Year	-53.85%
Cash/sh	0.88	P/FCF	19.29	EPS past 3/5Y	25.78% 21.74%	ROIC	40.28%	52W Low	45.05 20.69%	Perf 3Y	4.58%
Dividend Est.	1.82 (3.35%)	EV/EBITDA	8.36	Sales past 3/5Y	23.46% 18.15%	Gross Margin	83.94%	Volatility	1.89% 2.43%	Perf 5Y	47.70%
Dividend TTM	1.73 (3.18%)	EV/Sales	4.30	EPS Y/Y TTM	24.50%	Oper. Margin	46.36%	ATR (14)	1.68	Perf 10Y	99.12%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.56	Sales Y/Y TTM	21.52%	Profit Margin	35.60%	RSI (14)	38.20	Recom	2.03
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	39.83%	SMA20	-5.80%	Beta	0.66	Target Price	69.94
Payout	35.93%	Debt/Eq	0.59	Sales Q/Q	18.96%	SMA50	-3.13%	Rel Volume	0.81	Prev Close	56.09
Employees	76302	LT Debt/Eq	0.52	Earnings	Sep 26 AMC	SMA200	-20.96%	Avg Volume	17.99M	Price	54.37
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.02% 0.43%	Trades		Volume	14,596,257	Change	-3.07%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110

Show Previous Ratings

Oct-17-25 08:06PM	President Trump targets $150 MFN price for GLP-1s (CNBC TV)
04:39PM	Stock Market Today: Stocks Higher In Strong Week On Trump News; Oracle Dives (Live Coverage) (Investor's Business Daily)
04:38PM	Stock Market Today: Indexes Up In Strong Week On Trump News; Oracle Dives (Live Coverage) (Investor's Business Daily)
04:23PM	Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive. (Investor's Business Daily)
02:02PM	Stock Market Today: Dow Up As Financial Stocks Rise, Trump Tempers China Tariff View (Live Coverage) (Investor's Business Daily)
12:33PM	Loading…
12:33PM	Stock Market Today: Dow Higher As Moody's Chief Allays Bank Fears; Gold Stocks Dive (Live Coverage) (Investor's Business Daily)
11:44AM	NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs (Zacks)
10:58AM	Pharma Stocks Fall After Trump Says Ozempic Could Be Much Cheaper (The Wall Street Journal)
10:39AM	Novo, Lilly Fall as Trump Touts Much Lower Ozempic Price (Bloomberg)
10:16AM	Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, Fat Loss Drug Prices. (Barrons.com)
10:01AM	Trump says Ozempic will get much cheaper. Novo Nordisk and Eli Lilly shares tumble (Quartz)
09:43AM	Stock Market Today: Dow Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
09:36AM	Drugmakers slide on Trump comments, EssilorLuxottica's Meta glasses (Yahoo Finance Video)
09:35AM	Novo Nordisk Shares Fall After Trump Pledges Weight-Loss Drug Price Cuts (GuruFocus.com)
09:30AM	Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? (Zacks)
08:48AM	Loading…
08:48AM	Stock Market Today: Dow Edges Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
08:12AM	Stock Market Today: Dow Falls Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
07:35AM	Novo Nordisk falls on Trump threat to lower Ozempic prices and other morning movers (MarketWatch)
07:18AM	Eli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to Know. (Barrons.com)
06:22AM	The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics (Zacks)
Oct-16-25 05:45PM	Novo Nordisk (NVO) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
05:22PM	Novo Nordisk, Eli Lilly slide after Trump comments on weight loss drug pricing (Investing.com)
01:55PM	LLY's Oral GLP-1 Pill Scores Another Pair of Diabetes Wins (Zacks)
11:10AM	NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio (Zacks)
09:31AM	How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results? (Zacks)
03:39AM	A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now? (Motley Fool)
Oct-15-25 04:15PM	Novo Nordisk's Akero Therapeutics Buy Targets Eli Lilly's Lead (MarketBeat)
04:12PM	Omeros Catapults 154% On A Surprise $2.1 Billion Deal With Novo Nordisk (Investor's Business Daily)
03:26PM	Novo Nordisk Makes $2.1 Billion Rare-Disease Bet After Losing Ground in Obesity Race (GuruFocus.com)
12:49PM	Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk (Investor's Business Daily)
08:40AM	Loading…
08:40AM	Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026? (Zacks)
04:00AM	Meet the 1.4% Yield Dividend Stock That Could Soar in 2026 (Motley Fool)
Oct-14-25 09:00AM	Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Oct-13-25 07:23AM	The Smartest Growth Stock to Buy With $100 Right Now (Motley Fool)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
05:21AM	3 Top Healthcare Stocks to Buy in October (Motley Fool)
Oct-12-25 09:43AM	Should You Buy Novo Nordisk Right Now? (Motley Fool)
Oct-10-25 02:52PM	Bill Gates, PAHO Aim To Expand Global Access To Weight-Loss Drugs (GuruFocus.com)
02:43PM	Novo Nordisk to Close Cell Therapy Division Amid Global Restructuring (GuruFocus.com)
09:54AM	Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance? (Zacks)
06:35AM	Earnings, Fed Rates Mean Stocks Can Ignore the Shutdown. This Could Change That. (Barrons.com)
04:05AM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
Oct-09-25 05:45PM	Novo Nordisk (NVO) Dips More Than Broader Market: What You Should Know (Zacks)
04:04PM	Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $5.2 Billion Buyout (Investor's Business Daily)
11:17AM	Novo Nordisk Is Buying Akero Therapeutics. Its More Good News for Biotech Stocks. (Barrons.com)
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
10:11AM	Akero Therapeutics Stock Surges on Novo Nordisk Buyout (Schaeffer's Research)
07:31AM	Akero Therapeutics Stock Soars. Novo Nordisk Is Buying the Biotech for up to $5.2 Billion. (Barrons.com)
06:59AM	Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease (MarketWatch)
Oct-08-25 01:02PM	Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run (Investor's Business Daily)
Oct-07-25 02:58PM	Novo Nordisk Cuts Jobs At Key U.S. Drug Plant (GuruFocus.com)
02:57PM	Novo Nordisk Cuts U.S. Production Jobs Amid Global Restructuring (GuruFocus.com)
11:32AM	SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal (Zacks)
09:33AM	Where Will LLY Be in 5 Years? (Motley Fool)
Oct-06-25 11:09AM	What Makes Novo Nordisk A/S (NVO) a Promising and Profitable Investment in The Long Term? (Insider Monkey)
09:03AM	Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk (Zacks)
Oct-05-25 02:30PM	2 Beaten-Down Stocks Primed for a Comeback (Motley Fool)
Oct-03-25 05:45PM	Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know (Zacks)
04:55PM	5 Large Cap Drug Stocks: Values or Traps? (Zacks)
09:00AM	Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Oct-02-25 12:52PM	Buy Novo Nordisk Stock as Health Names Return to Favor, Analyst Says (Barrons.com)
11:15AM	Can Novo Nordisk's Restructuring Program Drive its Return to Growth? (Zacks)
Oct-01-25 06:46PM	Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight (Insider Monkey) +6.63%
01:27PM	Why Shares in Novo Nordisk Bumped Higher Today (Motley Fool)
10:01AM	What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices (Investor's Business Daily)
Sep-30-25 12:48PM	Trump's Plan To Lower U.S. Drug Prices Faces Big Test (Investor's Business Daily)
12:47PM	Denmark's Economy Wobbles as Novo Nordisk Loses Steam (GuruFocus.com)
11:02AM	Metsera Posts Promising Weight-Loss Drug Results. It Could Be a Win for Pfizer. (Barrons.com)
10:45AM	Can NVO Maintain Obesity Leadership With Next-Generation Candidates? (Zacks)
09:45AM	Why Novo Nordisk (NVO) is a Top Growth Stock for the Long-Term (Zacks)
08:18AM	Novo Nordisk Stock Falls After Morgan Stanley Issues Harsh Downgrade (GuruFocus.com)
Sep-29-25 06:05PM	Why Novo Nordisk Stock Slumped on Monday (Motley Fool)
04:44PM	Shareholders of Novo Nordisk A/S (NVO): Protect Your Rights Before September 30, 2025 - Contact Levi & Korsinsky (Newsfile)
02:08PM	Spotify initiated with Buy, Toyota August sales, Novo downgrade (Yahoo Finance Video)
10:13AM	Novo Nordisk Stock Is Downgraded. There's a 'Tough Path Ahead.' (Barrons.com)
06:07AM	Premarket movers: Merus, GSK, Novo Nordisk (MarketWatch)
05:36AM	Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating (MarketWatch)
04:59AM	M. Stanley cuts Novo Nordisk to Underweight on tough path ahead, shares slip (Investing.com)
Sep-28-25 03:01PM	Novo Nordisk: A Guru Buy Amid the Selloff -- Do LEAPS Make Sense? (GuruFocus.com)
Sep-27-25 06:45AM	3 Magnificent Stocks Under $100 to Buy Right Now (Motley Fool)
Sep-26-25 05:30PM	Trump Unveils 100% Drug Tariff, Pharma Stocks Slide (GuruFocus.com)
05:30PM	GLP-1 race evolves as Amgen & weight-loss pills enter the scene (Yahoo Finance Video)
05:00PM	Top Analyst Reports for NVIDIA, Berkshire Hathaway & Home Depot (Zacks)
03:49PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
03:15PM	Novo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights NVO (Business Wire)
12:34PM	Washington Is Disrupting Healthcare. 16 Stocks From Roundtable Pros That Can Win. (Barrons.com)
09:00AM	Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO (PR Newswire)
08:41AM	Novo Nordisk A/S (NVO) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 30, 2025 (Newsfile)
08:30AM	Trump's 100% Drug Tariffs Sparks Selloff in Global Pharma Markets (GuruFocus.com)
08:14AM	Intel, Wayfair, Eli Lilly, Oracle: Trending tickers (Yahoo Finance Video)
04:21AM	Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. (Motley Fool)
03:50AM	3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now (Motley Fool)
03:17AM	Trump Plans New Tariff Push With 100% Rate on Patented Drugs (Bloomberg)
Sep-25-25 09:30AM	Does This Acquisition Make Pfizer Stock a Great Buy? (Motley Fool)
09:15AM	Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up? (Zacks)
07:45AM	1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today (Motley Fool)
07:30AM	3 Reasons to Buy Novo Nordisk Stock Right Now (Motley Fool)
Sep-24-25 04:37PM	Novo Nordisk A/S (NVO) Attracts Park Avenue Securities Investment (Insider Monkey)
12:25PM	LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now? (Zacks)
Sep-23-25 06:55PM	Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock? (Zacks)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience